Medical Cannabis The Science. The Research. The Risk.

February 28, 2020

“Medical Cannabis: The science. The research. The risks.” is a full spectrum education program for the medical community. This conference held on November 15th, 2019 in New York focuses on the scientific and legal knowledge of healthcare professionals (physicians, pharmacists, physician assistants, nurse practitioners) and medical legal professionals. Anyone who wants to learn more about the science and potential liability surrounding cannabis will benefit from it.

CE | CME 5.75 Credits $249.00 USD

Narcolepsy and Excessive Daytime Sleepiness in OSA: Strategies to Improving Outcomes

January 26, 2020

In this program, sleep experts Dr. Richard Bogan (Chair), Dr. Yves Dauvilliers, Dr. Kiran Maski, Dr. Paula Schweitzer, and Dr. Michael Thorpy assess traditional and new therapies for treating patients with narcolepsy and EDS in OSA.

CME 2.00 Credits

Narcolepsy in Children: Addressing the Challenges and Improving the Outcomes

January 04, 2020

In this program, pediatric sleep disorder experts Kiran Maski, MD, MPH; Judith Owens, MD, MPH, and Michael Strunc, MD will describe best practices in diagnosis and treatment of narcolepsy.

CME 1.50 Credits

Narcolepsy in Children: Overcoming Barriers and Improving Outcomes

October 04, 2019

Narcolepsy in Children

CME 1.00 Credits

Reducing LDL-C and Cardiovascular Risk with Nonstatin Therapy: From Evidence to Practice

July 02, 2019

In this symposium, lipid experts Dr. Robert Giugliano, Dr. Marc Sabatine, and Dr. James Underberg will describe best practices for internists in managing LDL-C and reducing the risk for major cardiovascular events with the addition of nonstatin therapy.

CME 2.00 Credits

Managing LDL-C to Reduce Cardiovascular Disease Risk: Defining Best Clinical Practice

April 22, 2019

In this program, an expert faculty will discuss the evidence and recommendations for managing LDL-C in patients with ASCVD, familial hypercholesterolemia (FH), diabetes, and those at increased cardiovascular risk without ASCVD.

CME 2.00 Credits

Narcolepsy in Children: Insights into Diagnosis and Strategies to Improve Patient Care

December 30, 2018

In this program, pediatric sleep disorder experts Dr. Kiran Maski and Dr. Merrill Wise will describe strategies to overcome barriers in diagnosing narcolepsy in children, and explain best practices in treatment including emerging evidence with pharmacologic therapy.

No Credit Available

Fine-tuning the Management of Narcolepsy and Excessive Daytime Sleepiness in Obstructive Sleep Apnea

August 23, 2018

This program will focus on the diagnosis and treatment of narcolepsy and EDS in OSA. Format will consist of state-of-the-art lectures and debates chaired by Michael Thorpy, MD with faculty Michael Sateia, MD; Thomas Scammell, MD,Kingman Strohl, MD; Phyllis Zee, MD, PhD

No Credit Available

LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy

June 17, 2018

n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.

No Credit Available

Demystifying Narcolepsy in Children: Pathways to Successful Outcomes

November 15, 2017

In this symposium, experts will address best practices in the diagnosis and treatment of narcolepsy, and explore hypersomnia mimics of narcolepsy in children.

No Credit Available

Management of Narcolepsy and excessive Daytime Sleepines in Obstructive Sleep Apnea

August 09, 2017

In this program, sleep experts including Richard Bogan, MD (Chair), and Suresh Kotagal, MBBS provide valuable insights and best practices for diagnosing and treating narcolepsy in children and adults. Case Studies and in depth participation by Atul Malhotra, MD, Patrick Strollo Jr., MD, and Lisa Collins, RRT, RPSGT, RCP

No Credit Available